Extended field and total central lymphatic radiotherapy in the treatment of early stage lymph node centroblastic-centrocytic lymphomas: Results of a prospective multicenter study

Cancer

Volumn 80, Issue 12, 1997, Pages 2273-2284

  Stuschke, Martin ^a   Hoederath, Angela ^a,g   Sack, Horst ^a   Pötter, Richard ^b,h   Müller, Rolf P ^c   Schulz, Ulrich ^d   Karstens, Johann ^e   Makoski, Hans B ^f  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d Klinikum Krefeld   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f Klinikum Duisburg   (Germany)

^g Städtisches Krankhs Heilbronn ^*  (Germany)

^h UNIVERSITY OF VIENNA   (Austria)

Author keywords

Centroblastic centrocyctic lymphoma; Extended field radiotherapy; Non Hodgkins' lymphoma; Pattern of relapse; Total central lymphatic irradiation

Indexed keywords

ANTINEOPLASTIC AGENT; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYTARABINE; MITOXANTRONE; PREDNIMUSTINE; PREDNISONE; VINCRISTINE;

ACUTE MYELOMONOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; LEUKOPENIA; LYMPH NODE IRRADIATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RADIATION DOSE FRACTIONATION; THROMBOCYTOPENIA;

ADULT; AGED; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC IRRADIATION; LYMPHATIC METASTASIS; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RECURRENCE; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0031441145     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19971215)80:12<2273::AID-CNCR9>3.0.CO;2-V     Document Type: Article

References (70)

1. The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Cancer 1982; 49:2112-35.
2. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 1971;31:1860-1.
3. Gomez GA, Barcos M, Krishnamsetty RM, Panahon AM, Han T, Henderson ES. Treatment of early stages I and III nodular, poorly differentiated lymphocytic lymphoma. Am J Clin Oncol 1986;9:40-4.
4. Hagberg H, Pettersson U, Glimelius B, Sundström C. Prognostic factors in non-Hodgkin's lymphoma stage I treated with radiotherapy. Acta Oncol 1989;28.45-50.
5. Hoppe RT. The role of radiation therapy in the management of non-Hodgkin's lymphomas. Cancer 1985;55:2176-83.
6. Lawrence T, Urba W, Steinberg S, Sundeen J, Cossman J, Young R, et al. Retrospective analysis of stage I and II indolent lymphomas at the National Cancer Institute. Int J Radiat Oncol Biol Phys 1988;14:417-24.
7. Shipp MA, Mauch P, Harris NL. Non-Hodgkin's lymphomas. In: DeVita VT, Hellman S, Rosenberg SA. Cancer: principles and practice of oncology. 5th edition. Philadelphia: J. B. Lippincott, 1997:2165-220.
8. Sutcliffe SB, Gospodarowicz MK, Bush RS, Brown TC, Chua T, Bean HA, et al. Role of radiation therapy in localized non-Hodgkin's lymphoma. Radiother Oncol 1985;4:211-23.
9. Paryani SB, Hoppe RT, Cox RS, Colby TV, Rosenberg SA, Kaplan HS. Analysis of non-Hodgkin's lymphomas with nodular and favourable histologies, stages I and II. Cancer 1983;52:2300-7.
10. Pendlebury S, El Awadi M, Ashley S, Brada M, Horwich A. Radiotherapy results in early stage low grade nodal non-Hodgkin's lymphoma. Radiother Oncol 1995;36:167-71.
11. Reddy S, Saxena VS, Pellettiere EV, Hendrickson FR. Stage I and II non-Hodgkin's lymphomas: long-term results of radiation therapy. Int J Radiat Oncol Biol Phys 1989;16:687-92.
12. Rosenberg SA. The low-grade non-Hodgkin's lymphomas: challenges and opportunities. J Clin Oncol 1985:3;299-310.
13. Vaughan Hudson B, Vaughan Hudson G, MacLennan KA, Anderson L, Linch DC. Clinical stage I non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy. Br J Cancer 1994;69:1088-93.
14. Portlock CS. Management of the low-grade non-Hodgkin's lymphomas. Semin Oncol 1990;17:51-9.
15. Besa PC, McLaughlin PW, Cox JD, Fuller LM. Long term assessment of patterns of treatment failure and survival in patients with stage I and II follicular lymphoma. Cancer 1995;75:2361-7.
16. Gospodarowicz M, Bush R, Brown T, Chua T. Prognostic factors in nodular lymphomas: a multivariate analysis based on the Princess Margaret Hospital experience. Int J Radiat Oncol Biol Phys 1984;10:489-97.
17. Monfardini S, Banfi A, Bonadonna G, Rilke F, Milani F, Valagussa P, et al. Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 1980;6:125-34.
18. Gallagher CJ, Gregory WM, Jones AE, Stansfeld AG, Richards MA, Dhaliwal HS, et al. Follicular lymphoma: prognostic factors for response and survival. J Clin Oncol 1986;4:1470-80.
19. Taylor RE, Allan S, McIntyre M, Kerr G, Taylor A, Ritchie G, et al. Low grade stage I and II non-Hodgkin's lymphoma: results of treatment and relapse pattern following therapy. Clin Radiol 1988;39:287-90.
20. Carde P, Burgers JMV, van Glabbeke M, Hayat M, Cosset JM, Somers R, et al. Combined radiotherapy-chemotherapy for early stage non-Hodgkin's lymphoma: the 1975-1980 EORTC controlled lymphoma trial. Radiother Oncol 1984;2:301-12.
21. Chen MG, Prosnitz LR, Gonzalez-Serva A, Fischer DB. Results of radiotherapy in control of stage I and II non-Hodgkin's lymphoma. Cancer 1979;43:1245-54.
22. Soubeyran P, Eghbali H, Bonichon F, Coindre JM, Richaud P, Hoerni B. Localized follicular lymphomas: prognosis and survival of stage I and II in a retrospective series of 103 patients. Radiother Oncol 1988;13:91-8.
23. MacManus MP, Hoppe RT. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? results of a long-term follow-up study of patients treated at Stanford University. J Clin Oncol 1996;14:1282-90.
24. Paryani SB, Hoppe RT, Cox RS, Colby TV, Kaplan HS. The role of radiation therapy in management of stage III follicular lymphomas. J Clin Oncol 1984;2;841-8.
25. Cox J, Komaki R, Kun L, Wilson F, Greenberg M. Stage III nodular lymphoreticular tumors (non-Hodgkin's lymphoma): results of central lymphatic irradiation. Cancer 1981;47:2247-52.
26. Jacobs JP, Murray KJ, Schultz CJ, Wilson JF, Goswitz MS, Stevens CW, et al. Central lymphatic irradiation for stage III nodular malignant lymphoma: long-term results. J Clin Oncol 1993;11:233-8.
27. Mendenhall NP, Million RR. Comprehensive lymphatic irradiation for stage II-III non-Hodgkin's lymphoma. Am J Clin Oncol 1989;12:190-4.
28. Rappaport H, Winter WJ, Hicks EB. Follicular lymphoma: a reevaluation of its position in the scheme of malignant lymphoma based on a survey of 253 cases. Cancer 1956,9:792-821.
29. Lennert K. Histopathology of non-Hodgkin's lymphomas based on the Kiel classification. New York: Springer-Verlag, 1981.
30. Lukes RJ, Collins RD. Immunological characterization of human malignant lymphomas. Cancer 1974;34:1488-1503.
31. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92.
32. Stansfeld A, Diebold J, Kapanci Y, Kelenyi G, Lennert K, Mioduszewska O, et al. Updated Kiel classification for lymphomas. Lancet 1988;i:292-3.
33. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
34. SAS Institute, Inc. SAS/STAT User's Guide, Version 6. 4th edition. Volume 2. Cary, NC: SAS Institute, Inc.; 1989;1027-69.
35. Gaynor JJ, Feuer EJ, Tan CC, Wu DH, Little CR, Straus DJ, et al. On the use of cause-specific failure and conditional failure probabilities: examples from clinical oncology data. J Am Stat Assoc 1993:88;400-9.
36. Pepe MS. Interference for events with dependent risks in multiple endpoint studies. J Am Stat Assoc 1991;86:770-8.
37. Cox DR. Regression models and life tables. J R Soc Stat B1972; 34:187-220.
38. SAS Institute, Inc. SAS technical report P-229, SAS/STAT software. Release 6.07. Cary, NC: SAS Institute, Inc., 1992;435-79.
39. Bastion Y, Berger F, Bryon PA, Felman P, French M, Coiffier B. Follicular lymphomas: assessment of prognostic factors in 127 patients followed for 10 years. Ann Oncol 1991;2(Suppl 2); 123-9.
40. Cabanillas F, Smith T, Bodey GP, Gutterman JU, Freireich EJ. Nodular malignant lymphomas. Cancer 1979;44:1983-9.
41. International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993;329:987-94.
42. Leonard RFC, Hayward RL, Prescott RJ, Wang JX. The identification of discrete prognostic groups in low grade non-Hodgkin's lymphoma. Ann Oncol 1991;2:655-62.
43. Soubeyran P, Eghbali H, Bonichon F, Trojani M, Richaud P, Hoerni B. Low-grade follicular lymphomas: analysis of prognosis in a series of 281 patients. Eur J Cancer 1991;27:1606-13.
44. Cosset JM, Henry-Amar M, Meerwaldt JH, Carde P, Noordijk EM, Thomas J, et al. The EORTC trials for limited stage Hodgkin's disease. Eur J Cancer 1992;28A:1847-50.
45. Kaplan HS, Rosenberg SA. The treatment of Hodgkin's disease. Med Clin N Am 1966;50:1591-1610.
46. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, et al. Proposals for the classification of acute leukemias. Br J Haematol 1976;33:451-8.
47. Molenaar WM, Bartels H, Koudstaal J. Histological, epidemiological and clinical aspects of centroblastic-centrocytic lymphomas subdivided according to the Working Formulation. Br J Cancer 1984;49:263-8.
48. Brittinger G, Bartels H, Common H, and the Kiel Lymphoma Study Group. Clinical and prognostic relevance of the Kiel Classification of non-Hodgkin's lymphomas: results of a prospective multicenter study by the Kiel Lymphoma Study Group. Hematol Oncol 1984;2:269-306.
49. Fuks Z, Kaplan HS. Recurrence rates following radiation therapy of nodular and diffuse malignant lymphomas. Radiology 1973;108:675-84.
50. Berinstein NL, Jamal HH, Kuzniar B, Klock RJ, Reis MD. Sensitive and reproducible detection of occult disease in patients with follicular lymphoma by PCR amplification of t(14;18) both pre-and post-treatment. Leukemia 1993; 7:113-9.
51. Denham JW, Denham E, Dear KB, Hudson GV. The follicular non-Hodgkin's lymphomas. I. The possibility of cure. Eur J Cancer 1996;32A:470-9.
52. Finke J, Slanina J, Lange W, Dölken G. Persistence of circulating t(14;18) positive cells in long-term remission after radiation therapy for localized-stage follicular lymphoma. J Clin Oncol 1993;11:1668-73.
53. Cox JD, Koehl RH, Turner WM, King FM. Irradiation in the local control of malignant lymphoreticular tumors (non-Hodgkin's malignant lymphoma). Radiology 1974;112:179-85.
54. Bush RS, Gospodarowicz M, Sturgeon J, Alison R. Radiation therapy of localized non-Hodgkin's lymphoma. Cancer Treat Rep 1977;61:1129-36.
55. Gomez GA, Aggarwal KK, Han T. Post-therapeutic acute malignant myeloproliferative syndrome and acute nonlymphocytic leukemia in non-Hodgkin's lymphoma. Cancer 1982;50:2285-8.
56. Kolotas C, Zamboglou N, Schnabel T, Bojar H, Wintzer A, Vogt HG, et al. Effect of recombinant human granulocyte colony stimulating factor (r-metHuG-CSF) as an adjunct to large-field radiotherapy: a phase I study. Im J Radiat Oncol Biol Phys 1996;35:137-42.
57. Adamietz IA, Rosskopf B, Dapper FD, vonLieven H, Boetcher HD. Comparison of two strategies for the treatment of radiogenic leukopenia using granulocyte colony stimulating factor. Int J Radiat Oncol Biol Phys 1996;35:61-7.
58. Farese AM, Herodin F, McKearn JP, Baum C, Burton E, MacVittie TJ. Acceleration of hematopoietic reconstitution with a synthetic cytokine (SC55494) after radiation-induced bone marrow aplasia. Blood 1996;87:581-91.
59. Kaushansky K, Lok S, Holly RD, Broudy VC, Lin N, Bailey MC, et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-mpl ligand thrombopoietin. Nature 1994;369:568-72.
60. Yahalom J, Varsos G, Fuks Z, Myers J, Clarkson BD, Straus DJ. Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin's lymphoma. Cancer 1993;71:2342-50.
61. Nissen NI, Ersboll J, Hansen HS, Walbom-Jorgensen S, Pedersen-Bjergaard J, Hansen MM, et al. A randomized study of radiotherapy plus chemotherapy in stage I-II non-Hodgkin's lymphomas. Cancer 1983;52:1-7.
62. Landberg TG, Håkansson LG, Möller TR, Mattsson WKI, Landys KE, Johansson BG, et al. CVP remission maintenance in stage I or II non-Hodgkin's lymphomas. Cancer 1979; 44:831-8.
63. Kelsey SM, Newland AC, Vaughan Hudson G, Jelliffe AM. A British National Lymphoma Investigation randomised trial of single agent chlorambucil plus radiotherapy versus radiotherapy alone in low grade, localised non-Hodgkin's lymphoma. Med Oncol 1994;11:19-25.
64. Bierman PJ, Vose J, Armitage J, Kessinger A. High-dose therapy followed by autologous hematopoietic rescue for follicular low grade non-Hodgkin's lymphoma. Proc Am Soc Clin Oncol 1992;11:1074.
65. Freedman A, Neuberg D, Gribben J, Mach P, Anderson K, Soiffer R, et al. Autologous bone marrow transplantation in relapsed low grade non-Hodgkin's lymphoma. Blood 1994;84(Suppl 1):203.
66. Haas R, Moos M, Karcher A, Möhle R, Witt B, Goldschmidt H, et al. Sequential high-dose therapy with peripheral blood progenitor cell support in low-grade non-Hodgkin's lymphoma. J Clin Oncol 1995;12:1685-92.
67. Rohatiner A, Freedman A, Nadler L, Lim J, Lister TA. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for follicular lymphoma. Ann Oncol 1994;5(Suppl 2):143-6.
68. Schouten HC, Colombat P, Verdonck LF. Autologous bone marrow transplantation for low-grade non-Hodgkin's lymphoma: the European Bone Marrow Transplant Group experience. Ann Oncol 1994;5(Suppl 2):147-9.
69. Unterhalt M, Herman R, Koch P, Trümper L, Bodenstein H, Dietzfelbinger H, et al. Significant prolongation of disease free interval in advanced low grade non-Hodgkin's lymphomas by interferon alpha maintenance and its relation to initial cytoreductive treatment. Ann Oncol 1996;7(Suppl 3):55.
70. McLaughlin P, Grillo-López AJ, Czuczman M, Link BK, Dillman RO, Ho AD, et al. Pivotal phase III clinical trial of the chimeric anti-CD20 antibody IDEC-C2B8 in patients with relapsed low-grade follicular lymphoma: a preliminary report. Ann Oncol 1996;7(Suppl 3):57.